-
-
GLP-1 Side Chains
显示更多 -
Peptide Intermediates
-
Fmoc-His-Aib-OH
-
Fmoc-Ile-Aib-OH
-
Fmoc-Tyr(tBu)-Aib-OH
-
Fmoc-Glu(OtBu)-Aib-OH
-
Fmoc-His(Fmoc)-Aib-OH
-
Fmoc-His(Fmoc)-Aib-OSu
显示更多 -
-
Tirzepatide Fragments
-
CAS:2682040-93-1
-
CAS:3034670-52-2
-
CAS:1262308-37-1
-
CAS:2461524-68-3
-
CAS:2656383-24-1
-
CAS:2656383-25-2
显示更多 -
-
API & Excipients
显示更多 -
Cosmetic Peptides
-
Oligopeptide-1
-
NonaPeptide-1
-
Copper Tripeptide-1
-
Acetyl Hexapeptide-8
-
Palmitoyl Tripeptide-1
-
Decarboxy Carnosine HCl
显示更多 -
-
Active Ingredients
显示更多
-
Working Together to Create Excellence - The 2024 Congen Pharma Annual Meeting and Expansion Activities Successfully Concluded
Publish Time:
2024-12-31

At the beginning of the new year, everything is renewed. Recently, Congen Pharma's 2024 year-end meeting and expansion activities were successfully held, jointly reviewing the past year's struggles and achievements, looking forward to the opportunities of 2025, and drawing a new blueprint for high-quality development!

Opening
At the beginning of the annual meeting, Mr. Zheng Qingquan, chairman of Congen Pharma, delivered a speech, summarizing the achievements and challenges of the past year, and putting forward new expectations for the development of the new year. He emphasized that 2025 is a year full of opportunities, and the company will continue to innovate in research and development, expand its business, and enhance its core competitiveness. With the start of the new journey, all Congen people will forge ahead and create a better future together!

Report
Heads of various departments reported on the work achievements in 2024, focusing on summarizing and reviewing sales target achievement, R&D results, and team management. At the same time, they also observed the market "time" and "trend", planned and deployed work for the new year, and actively offered suggestions for the high-quality development of Congen Pharma.
Commendation
In the past year, a number of outstanding employees and teams have emerged in Congen Pharma. They are the practitioners of corporate culture, the main force in business development, and the leaders of independent research and development and innovation. In the commendation session, awards such as Innovation Star, Quality Star, Management Star, Best Newcomer, and Best Team were presented, encouraging every Congen person to forge ahead with honors.


Expansion
To thank everyone for their hard work over the past year, the company organized an expansion activity in Zhaoqing. The team, with firm belief, successfully climbed to the top of Dinghushan Mountain and completed a hike in the Lingyangxia Ancient Plank Road Forest Park, sharing the joy of overcoming challenges together.


Conclusion
Looking back at 2024, it was a year of riding the wind and waves and unwavering efforts;
Looking forward to 2025, it is a time of fierce competition, where those who strive will be the first.
In the new year, we will work together to create a beautiful future and open a new chapter for Congen Pharma!
Relevant Information
Sorry,当前栏目暂无内容!
您可以查看其他栏目或返回 首页
Sorry,The current column has no content!
You can view other columns or return Home